
Manufacturing is one of the biggest users of R&D tax relief for manufacturing in the UK — the sector accounts for around a quarter of all R&D claims (24% in HMRC's 2022-23 statistics). Yet many manufacturers still under-claim, because the everyday work of solving production problems, developing new products and pushing processes further doesn't always feel like "research". If your team is overcoming genuine technical uncertainty — not just applying known methods — a share of that work very likely qualifies.
This guide sets out which manufacturing projects and costs qualify, how the current merged scheme works, and the sector-specific traps that trigger HMRC enquiries.
The tax definition is the same across every sector, and it's stricter than the everyday meaning. A project qualifies only if it seeks an advance in science or technology by resolving scientific or technological uncertainty that a competent professional couldn't readily work out. This is set out in HMRC's manual at CIRD81900.
Two tests matter for manufacturing claims:
For a fuller walk-through, see our guides to qualifying R&D activities and evidencing technological uncertainty.
Qualifying work usually pushes beyond what established methods, materials or equipment can reliably deliver:
Knowing where HMRC pushes back matters just as much:
For a qualifying project, you claim an apportioned share of these cost categories:
The prototype-sold trap. Materials consumed building a prototype to resolve a technical uncertainty can qualify — but if you then sell that prototype as a finished product, the consumable cost may be restricted, because it wasn't ultimately "consumed" in the R&D. This is one of the most common manufacturing claim errors; see our note on prototype eligibility.
For accounting periods beginning on or after 1 April 2024, most companies claim under the merged R&D scheme: a 20% above-the-line expenditure credit on qualifying costs (taxable, so the net benefit is lower after Corporation Tax).
Loss-making, R&D-intensive SMEs get a better deal under the Enhanced R&D Intensive Scheme (ERIS): if qualifying R&D is at least 30% of total relevant expenditure (CIRD123000), you can claim a more generous payable credit. A manufacturer investing heavily in a new process or product line can tip into that bracket, so it's worth checking your intensity ratio before defaulting to the merged scheme.
The same principles apply across sectors — see our companion guide to R&D tax relief for engineering firms.
With HMRC checking around one in five R&D claims, evidence is everything:
Zest helped Genuine Jay Jays make a substantial claim for innovative manufacturing techniques — a worked illustration of how process and product development on the factory floor translates into a robust R&D claim. See the full Jay Jays manufacturing case study.
Yes — manufacturing is one of the largest claiming sectors, around a quarter of all UK R&D claims. The work must seek an advance in science or technology by resolving technological uncertainty a competent professional couldn't readily overcome, such as new products, processes, tooling or materials. Routine production doesn't qualify.
It can. Developing a manufacturing process that's more precise, faster, less wasteful or more repeatable qualifies where the outcome was genuinely uncertain and required systematic investigation — not where you're applying a known method. Process innovation is one of the most commonly missed qualifying areas in manufacturing. For a high-precision example, see our aerospace-sector R&D guide.
Materials consumed building a prototype to resolve a technical uncertainty can usually be claimed. But if the prototype is later sold as a finished product, the consumable cost may be restricted because it wasn't ultimately consumed in the R&D — this needs careful treatment.
For accounting periods beginning on or after 1 April 2024, most companies use the merged R&D scheme (a 20% expenditure credit). Loss-making manufacturers whose R&D is at least 30% of total expenditure may instead claim the more generous ERIS.

HMRC’s R&D tax credit statistics 2026 show SME claims down 19% even as total relief rises — what’s behind the fall and what it means for your claim.

How does the Patent Box work? A plain-English guide to the 10% Corporation Tax rate on patent profits — eligibility, the development condition, the R&D nexus, how to elect, and a worked example.

The Chancellor will deliver the Autumn Budget 2026 on Wednesday 28 October. For any UK company running an R&D tax relief claim — or planning its first — it is worth knowing what is genuinely on the table before the red box opens, and what is simply noise. The short version: after three years of near-constant reform, the R&D regime is finally settling. Most of what matters for your next claim is already law. But a Budget always carries the risk of a technical tweak, and there are a few signals worth tracking. Where the R&D rules stand going into the Budget The big structural change is done. The merged RDEC scheme is now the default for accounting periods beginning on or after 1 April 2024, replacing the old separate SME and RDEC regimes. It gives a taxable expenditure credit of 20% of qualifying R&D costs — worth roughly 15% net once Corporation Tax at 25% is applied. Loss-making, R&D-intensive SMEs are the exception. If your qualifying R&D is at least 30% of total expenditure, you may instead claim under Enhanced R&D Intensive Support (ERIS), which offers a more generous deduction and a payable credit for surrenderable losses. None of […]